Algorithme Pharma Inc.

As a worldwide leader in clinical research and bioanalysis, Algorithme Pharma provides a wide range of services for bioequivalence and early stage development (Phase I/IIa) studies to the generic, pharmaceutical, and bio-technology industries. In addition to its multi-unit clinical facilities in Canada, the United States and the United Kingdom (more than 400 beds) and with its new dedicated state-of-the-art facility for Phase I clinical trials in Montreal, Algorithme Pharma offers different services including protocol designs, CTD/ICH clinical reports, data management, biostatistics, quality assurance (QA) and regulatory affairs.